Rate My Professor Gregory Hendey

Gregory W. Hendey, MD, is Chair of the Department of Emergency Medicine and Professor of Clinical Emergency Medicine in the Medicine faculty at the University of California, Los Angeles David Geffen School of Medicine, where he holds the Marshall T. Morgan Endowed Chair. He earned a Bachelor of Science in Psychology from the University of Notre Dame in 1985 and a Doctor of Medicine from Vanderbilt University School of Medicine in 1989. Hendey completed an internship in internal medicine in 1990 and a residency in emergency medicine in 1993 at UCLA, serving as chief resident from 1992 to 1993. After residency, he joined the emergency medicine faculty at UCSF Fresno, advancing to research director in 2000, vice chief in 2007, and chief in 2012, overseeing one of California's busiest emergency departments and trauma centers. In June 2016, he returned to UCLA as the inaugural chair of the newly established Department of Emergency Medicine, emphasizing teaching, research, clinical operations, and collaboration across UCLA sites.

Hendey's academic interests center on emergency medicine, with specializations in blunt trauma, head injury, chest imaging, and critical care interventions. He has collaborated on federally funded multicenter trials, including those supported by the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, and as co-principal investigator for the National Institutes of Health-funded PETAL network on prevention and early treatment of acute lung injury. His teaching excellence earned him the Henry J. Kaiser Award for Excellence in Teaching from UCSF School of Medicine and a National Faculty Teaching Award from the Council of Emergency Medicine Residency Directors. Hendey serves as associate editor of a major emergency medicine textbook and decision editor for Annals of Emergency Medicine. Notable publications include "Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial" (JAMA, 2024), "Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial" (JAMA, 2020), "Derivation and validation of two decision instruments for selective chest CT in blunt trauma: a multicenter prospective observational study (NEXUS Chest CT)" (PLoS Med, 2015), and "NEXUS chest: validation of a decision instrument for selective chest imaging in blunt trauma" (JAMA Surg, 2013).